Stanford Health Care's expertise in the prevention, diagnosis and treatment of skin cancer is now available to a group of patients whose risk for non-melanoma forms of skin cancer is higher than most. For hundreds of thousands of us, including those who live with an organ transplant, who must take medications that suppress the immune system, the odds of developing skin cancer become very high. Learn in this video about the ways the new Stanford High-Risk Skin Cancer Clinic offers a special sensitivity to that risk—and advanced prevention and treatments, including clinical trials and a tumor board.